You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sorafenib

Showing 51 - 75 of 1,094
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in United States (Sorafenib, Letrozole)

Terminated
  • Metastatic Breast Cancer
  • Washington, District of Columbia
  • +3 more
Sep 21, 2021

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (TACE combined with sorafenib/lenvatinib and iodion-125 seeds

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • TACE combined with sorafenib/lenvatinib and iodion-125 seeds brachytherapy
  • TACE combined with sorafenib/lenvatinib
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Jul 27, 2021

Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in Richmond (drug, radiation, other)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Oct 20, 2021

Hepatocellular Carcinoma Trial in Albuquerque (Sorafenib & Capecitabine)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • Sorafenib & Capecitabine
  • Albuquerque, New Mexico
  • +2 more
May 11, 2021

NSCLC Trial in United States (Erlotinib + Sorafenib, Erlotinib + Placebo)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Erlotinib + Sorafenib
  • Erlotinib + Placebo
  • Fort Myers, Florida
  • +15 more
Feb 15, 2022

Hepatocellular Cancer, Liver Cancer Trial in Tampa (Trametinib, Sorafenib)

Completed
  • Hepatocellular Cancer
  • Liver Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 9, 2021

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Baltimore (Bone Marrow Transplantation, Sorafenib, Sorafenib Tosylate)

Completed
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Bone Marrow Transplantation
  • +2 more
  • Baltimore, Maryland
  • +1 more
May 27, 2021

Metastatic Renal Cell Carcinoma Trial in Italy (sorafenib)

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • sorafenib
  • Milan, Mi, Italy
  • +13 more
Sep 16, 2021

Hepatocellular Carcinoma Trial in Shanghai (Toripalimab, Sorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, China
    Zhongshan Hospital
Jun 14, 2021

Radiomics, Hepatocellular Carcinoma (HCC), Transcatheter Arterial Chemoembolization (TACE) Trial in Guangzhou (Sorafenib,

Active, not recruiting
  • Radiomics
  • +4 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 5, 2023

Hepatocellular Cancer Trial in Shanghai (hepatic resection, Sorafenib)

Recruiting
  • Hepatocellular Cancer
  • hepatic resection
  • Sorafenib
  • Shanghai, China
    Eastern Hepatobiliary Surgery Hospital
Apr 8, 2021

Metastatic Colorectal Cancer Trial in France (Nexavar (Sorafenib) and irinotecan (Campto))

Completed
  • Metastatic Colorectal Cancer
  • Nexavar (Sorafenib) and irinotecan (Campto)
  • Lille, France
  • +4 more
Jun 17, 2021

Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Hepatocellular Carcinoma Trial in Worldwide (Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Sorafenib
  • Tucson, Arizona
  • +23 more
Apr 16, 2021

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer Trial in

Active, not recruiting
  • Adult Primary Hepatocellular Carcinoma
  • +2 more
  • sorafenib tosylate
  • stereotactic body radiation therapy
  • Berkeley, California
  • +50 more
Nov 17, 2022

Radiotherapy, Toripalimab, Sorafenib Trial in Beijing (Radiotherapy plus Toripalimab, Sorafenib)

Recruiting
  • Radiotherapy
  • +3 more
  • Radiotherapy plus Toripalimab
  • Sorafenib
  • Beijing, Beijing, China
    Bo Chen
Mar 6, 2021

Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination

Not yet recruiting
  • Elderly AML Patients
  • +4 more
  • Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
  • Active Comparator: Standard dose of Venetoclax + Azacitidine
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
Oct 3, 2023

Liver Cancer Trial in Houston (Bevacizumab, Erlotinib)

Completed
Has Results
  • Liver Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 3, 2022

Solid Tumor Trial in Taipei (MG005)

Completed
  • Solid Tumor
  • Taipei, Nehu District, Taiwan
    Tri-Service General Hospital
Apr 23, 2021

Hepatocellular Carcinoma Trial in Hangzhou (Sorafenib, S-1, Oxaliplatin)

Withdrawn
  • Hepatocellular Carcinoma
  • Sorafenib
  • +2 more
  • Hangzhou, China
    First affiliated hospital, Zhejiang University
Feb 12, 2021

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022

Carcinoma, Hepatocellular Trial in Navi Mumbai (radiation, procedure, drug)

Recruiting
  • Carcinoma, Hepatocellular
  • SBRT
  • +2 more
  • Navi Mumbai, Maharashtra, India
  • +1 more
Apr 25, 2022

Overall Survival, Tumor Responses Trial in Taichung (Atorvastatin 10mg, Placebo Oral Tablet)

Terminated
  • Overall Survival
  • Tumor Responses
  • Atorvastatin 10mg
  • Placebo Oral Tablet
  • Taichung, Taiwan
    Taichung Veterans General Hospital
Mar 14, 2021

Carcinoma, Hepatocellular Trial in Seoul (Avelumab)

Completed
  • Carcinoma, Hepatocellular
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 15, 2021

Hepatocellular Carcinoma Trial in Nanning (DEB-TACE plus Sorafenib, DEB-TACE plus Lenvatinib, DEB-TACE plus PD-1 inhibitor)

Recruiting
  • Hepatocellular Carcinoma
  • DEB-TACE plus Sorafenib
  • +2 more
  • Nanning, Guangxi, China
    Guangxi Medical University Cancer Hospital
Feb 7, 2021